Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease

GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice

(2010) J. Chang et al.   BLOOD

Aptamers as therapeutics

(2010) Anthony D. Keefe et al.   NATURE REVIEWS DRUG DISCOVERY

Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779

(2009) J. L. DIENER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura

(2009) Paul Knöbl et al.   TRANSFUSION

The vessel wall and its interactions

(2008) D. D. Wagner et al.   BLOOD

Aptamers as candidate therapeutics for cardiovascular indications

(2008) A KEEFE et al.   CURRENT OPINION IN PHARMACOLOGY

A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor

(2008) M. Y. CHAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion

(2007) J. Chang et al.   BLOOD